ReviewPossible mechanisms of cannabinoid-induced antinociception in the spinal cord
Introduction
Derivatives of cannabis sativa, endogenous ligands of the cannabinoid CB1 receptor, such as anandamide and 2-arachidonoylglycerol, synthetic cannabinoid CB1 receptor agonist molecules and inhibitors of the cannabinoid re-uptake system have been shown to produce antinociceptive or antihyperalgesic effects in various animal models of pain Calignano et al., 1998, Herzberg et al., 1997, Mao et al., 2000, Martin et al., 1998, Martin et al., 1999, Mazzari et al., 1996, Richardson et al., 1998a, Richardson et al., 1998b, Smith et al., 1998, Strangman et al., 1998, Vivian et al., 1998, Welch et al., 1998. In addition, there is anecdotal clinical evidence that marijuana-smoking attenuates pain in multiple sclerosis patients (Consroe et al., 1997).
Cannabinoids activate two known receptor subtypes: the cannabinoid CB1 and CB2 receptors. The cannabinoid CB1 receptor is broadly found in the central and peripheral nervous systems, while the cannabinoid CB2 receptor is expressed in non-neuronal cells. The antinociceptive effects of endogenous and exogenous cannabinoids are exerted primarily via the cannabinoid CB1 receptor, which is coupled with Gi/Go proteins Matsuda et al., 1990, Munro et al., 1993. Activation of the cannabinoid CB1 receptor leads to inhibition of adenylyl cyclase activity Felder et al., 1995, Howlett and Fleming, 1984. In addition, cannabinoid CB1 receptor activation inhibits Ca2+ currents Caulfield and Brown, 1992, Twitchell et al., 1997 and modulates various potassium currents Deadwyler et al., 1995, Mackie et al., 1995, Poling et al., 1996 at different sites in the central nervous system (CNS).
In general, cannabinoids inhibit glutamatergic transmission in the brain Levenes et al., 1998, Shen et al., 1996, Szabo et al., 2000 and participate in the control of neuronal excitability and firing McAllister et al., 1999, Mu et al., 1999, Pan et al., 1998, Poling et al., 1996, Schweitzer, 2000, Shen et al., 1996.
Cannabinoid CB1 receptors are expressed in supraspinal Herkenham et al., 1991, Katona et al., 1999, Litchman et al., 1996, Mailleux and Vanderhaeghen, 1995, Martin et al., 1996, Martin et al., 1998, Tsou et al., 1998, spinal Farquhar-Smith et al., 2000, Herkenham et al., 1991, Tsou et al., 1998 and peripheral Ahluwalia et al., 2000, Hohmann and Herkenham, 1999 centres associated with nociceptive processing. Strong immunostaining of cannabinoid CB1 receptors in the dorsal horn and in the dorsal root ganglia suggests that one of the major sites of antinociceptive action is the spinal cord. This is supported by behavioural studies using intrathecal injection of cannabinoid receptor agonists Litchman and Martin, 1991, Mao et al., 2000, Richardson et al., 1998a, Richardson et al., 1998b, Richardson et al., 1998c, electrophysiological extracellular recordings Hohmann et al., 1995, Hohmann et al., 1998, Hohmann et al., 1999 and inhibition of C-fibre induced neurotransmitter release in the spinal cord (Drew et al., 2000).
Section snippets
Anatomical evidence for cannabinoid-induced presynaptic modulation of the spinal nociceptive synaptic transmission
Hohmann and Herkenham (1999) have shown that the spinal binding of cannabinoid CB1 receptor ligands was decreased by about 50% after dorsal rhizotomy suggesting that cannabinoid CB1 receptor are expressed both on primary sensory fibres and other structures in the spinal dorsal horn. However, neonatal capsaicin injection, which induces degeneration of the majority of nociceptive primary sensory neurons, produces only a moderate decrease in cannabinoid receptor binding in the spinal dorsal horn
Functional significance of the cannabinoid CB1 receptor expression on capsaicin-sensitive nociceptive primary sensory neurons
Further evidence for the putative location of cannabinoid CB1 receptors in the spinal dorsal horn has been provided by Morisset and Urban (2001) by using the patch-clamp recording technique in substantia gelatinosa neurons. Synthetic cannabinoids, such as (R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN55,212-2) reduced the frequency but not the amplitude of miniature excitatory postsynaptic currents (mEPSCs) and EPSCs
Concentration-related effects of anandamide: a dynamic presynaptic modulatory system in the dorsal horn?
An exciting aspect of cannabinoid CB1 receptor and vanilloid VR1 receptor co-expression was raised after recent findings by Zygmund et al. (1999) suggesting that anandamide, the endogenous cannabinoid CB1 receptor ligand, although at high concentrations (Tognetto et al., 2001), also activates the vanilloid VR1 receptor.
We investigated this dual effect of anandamide on nociceptive primary afferents by using patch-clamp recordings from substantia gelatinosa neurons. Anandamide at 1 μM
Summary
In summary, morphological and physiological evidences suggest a strong presynaptic cannabinoid CB1 receptor-mediated modulation of the nociceptive input to substantia gelatinosa neurons in the spinal cord. The attenuation of the capsaicin-induced increase in excitability and depolarisation of the substantia gelatinosa cells suggests that the strong inhibitory effect of the cannabinoids is able to reduce the nociceptive input to the spinal dorsal horn. This strong inhibitory effect is likely to
References (67)
- et al.
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
Neuroscience
(2000) - et al.
Cannabinoid CB1 receptor expression in rat spinal cord
Mol. Cell. Neurosci.
(2000) - et al.
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
Neurosci. Lett.
(1997) - et al.
Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment
Neurosci. Lett.
(1998) - et al.
Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study
Neuroscience
(1999) - et al.
Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN55,212-2
Life Sci.
(1995) - et al.
Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2
Neurosci. Lett.
(1998) - et al.
Two distinctive antinociceptive systems in rats with pathological pain
Neurosci. Lett.
(2000) - et al.
Antinociceptive actions of cannabinoids following intra-ventricular administration in rats
Brain Research
(1993) - et al.
Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla
Neurosci. Lett.
(1998)